Quovadis Epps, PharmD

Associate Professor, Pharmacy Practice Jacksonville Instructional Site
LOCATION: 2050 Art Museum Drive Bldg. 4800, Ste. 200 Jacksonville, FL 32207
EMAIL: quovadis.epps@famu.edu
PHONE: 904-346-5033
Biosketch
Quovadis Epps, PharmD, serves as Associate Professor of Pharmacy Practice at the Jacksonville Instructional Site. Dr. Epps obtained her Doctor of Pharmacy degree from Florida A& M University College of Pharmacy and Pharmaceutical Sciences. Upon graduation, she began her pharmacy career in hospital practice as a Staff Pharmacist. After two years in practice, she left her position to pursue a PGY1 Pharmacy Residency. Upon completion, she continued her education by completing a two-year Masters in Health-System Pharmacy Administration and Residency. Dr. Epps spent 15 years of her career working in the hospital setting servicing both adult and pediatric patients before transitioning to academia. Dr. Epps is a Board Certified Pharmacotherapy Specialist. In the College of Pharmacy, she assists in the training of Doctor of Pharmacy Candidates during her Adult Medicine rotation. Dr. Epps serves as the Residency Program Director for the Jacksonville Instructional Site. She is also the course coordinator for Population-Based Care I.

EDUCATION

Areas of Expertise

Internal Medicine

Research Interest
  • Post Graduate Training

  • Active Learning Strategies

  • Anticoagulation

  • Infectious Disease

  • Population Health

Selective Publications
  • Epps QJ, Epps KL, Young DC, Zobell JT. State of the art in cystic fibrosis pharmacology— Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti‐methicillin‐resistant Staphylococcus aureus (MRSA) antibiotics. Pediatric Pulmonology. 2019;1–25. https://doi.org/10.1002/ppul.24537

  • Barr, D. & Epps, Q.J. Direct oral anticoagulants: a review of common medication errors. J Thromb Thrombolysis (2019) 47: 146. https://doi.org/10.1007/s11239-018-1752-9

  • Epps KL, Epps QJ, Mourad H, Reger EB, Libertin CR. Is Annual Cumulative Susceptibility Test Data Enough to Guide Empirical Therapy for Pseudomonas aeruginosa Pneumonia?. Am J Clin Microbiol Antimicrob. 2018; 1(6): 1026